File:EMTMET intermediates. (A–E) Intermediate cells hybrid partial EMT cells.jpg

Original file (4,222 × 2,718 pixels, file size: 600 KB, MIME type: image/jpeg)

Captions

Captions

Add a one-line explanation of what this file represents

Summary

edit
Description Figure 3 EMT/MET intermediates. (A–E) Intermediate cells: hybrid/partial EMT (pEMT) cells. nth: The transition phase indicates the number of transitions that may occur before M cells are formed, which is indeterminate but could be dictated by many factors including the tumour microenvironmental cues. Intermediate cells possess dynamic characteristics that are central to increased metastatic potential. Hybrid/pEMT “C”: indicates an unspecific hypothetical stage. The time taken (known as first arrival time (FAT) distribution) for E or M cells to transition to each other, or individual pMET/hybrid cell at the nth phase varies depending on (i) epigenetic changes (histone modification or methylation), (ii) presence of anti-EMT/pro-MET factors (such as OVOL 1/2, GRHL-2, ESRP-1/2, and various microRNAs (including miR20 family), among others. Generally, the stability of hybrid E/M is controlled by some factors known as phenotypic stability factors (PSFs) and their metabolic, genomic, and morphologic states. However, as these intermediate cells possess some similar characteristics, they also have different phenotypic behaviours. They possess identical properties such as tumour-initiating potential but are also significantly contrastive, based on (i) cellular plasticity, (ii) degree of invasiveness, and (iii) metastatic potential. Among all the intermediate phenotypes, however, intermediate M possesses the highest migratory potential, the highest degree of invasiveness, most primed to form spindle-shaped phenotype and the highest resistance to anoikis.
Date
Source https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.762817/full Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors. Front. Oncol. 11:762817. doi: 10.3389/fonc.2021.762817
Author Imodoye SO, Adedokun KA, Muhammed AO, Bello IO, Muhibi MA, Oduola T and Oyenike MA
This file, which was originally posted to an external website, has not yet been reviewed by an administrator or reviewer to confirm that the above license is valid. See Category:License review needed for further instructions.

Copyright © 2021 Imodoye, Adedokun, Muhammed, Bello, Muhibi, Oduola and Oyenike. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Licensing

edit
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current10:11, 19 May 2024Thumbnail for version as of 10:11, 19 May 20244,222 × 2,718 (600 KB)Rasbak (talk | contribs){{Information |description=Figure 3 EMT/MET intermediates. (A–E) Intermediate cells: hybrid/partial EMT (pEMT) cells. nth: The transition phase indicates the number of transitions that may occur before M cells are formed, which is indeterminate but could be dictated by many factors including the tumour microenvironmental cues. Intermediate cells possess dynamic characteristics that are central to increased metastatic potential. Hybrid/pEMT “C”: indicates an unspecific hypothetical stage. The...

There are no pages that use this file.

Metadata